Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment of Alzheimer’s Disease: Trazodone, Sleep, Serotonin, Norepinephrine, and Future Directions
J. Wesson Ashford
Journal of Alzheimer s Disease (2019) Vol. 67, Iss. 3, pp. 923-930
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Regulation of Neurotransmitters by the Gut Microbiota and Effects on Cognition in Neurological Disorders
Yijing Chen, Jinying Xu, Yu Chen
Nutrients (2021) Vol. 13, Iss. 6, pp. 2099-2099
Open Access | Times Cited: 526
Cornuside ameliorates cognitive impairments in scopolamine induced AD mice: Involvement of neurotransmitter and oxidative stress
Zexing Wang, Wenwen Lian, Jun He, et al.
Journal of Ethnopharmacology (2022) Vol. 293, pp. 115252-115252
Closed Access | Times Cited: 28
Sleep–Wake Disorders in Alzheimer’s Disease: A Review
Yu-Ying Sun, Zhun Wang, He-Yan Zhou, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 10, pp. 1467-1478
Closed Access | Times Cited: 19
Physical Exercise as Disease-Modifying Alternative against Alzheimer’s Disease: A Gut–Muscle–Brain Partnership
Debora Cutuli, Davide Decandia, Giacomo Giacovazzo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14686-14686
Open Access | Times Cited: 12
Alzheimer's disease: a comprehensive review of epidemiology, risk factors, symptoms diagnosis, management, caregiving, advanced treatments and associated challenges
Saeid Safiri, Amir Ghaffari Jolfayi, Asra Fazlollahi, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 4
DOTA: Deep Learning Optimal Transport Approach to Advance Drug Repositioning for Alzheimer’s Disease
Jacqueline Chyr, Haoran Gong, Xiaobo Zhou
Biomolecules (2022) Vol. 12, Iss. 2, pp. 196-196
Open Access | Times Cited: 17
Gut-Brain Axis and Neurological Disorders-How Microbiomes Affect our Mental Health
Nirav Bhatia, Manjiri P. Jalgaonkar, Anuja Balu Hargude, et al.
CNS & Neurological Disorders - Drug Targets (2022) Vol. 22, Iss. 7, pp. 1008-1030
Closed Access | Times Cited: 15
New frontiers in Alzheimer's disease diagnostic: Monoamines and their derivatives in biological fluids
Alessandra Gallo, Laure‐Elise Pillet, Romain Verpillot
Experimental Gerontology (2021) Vol. 152, pp. 111452-111452
Open Access | Times Cited: 18
Synthesize heterogeneous biological knowledge via representation learning for Alzheimer’s disease drug repurposing
Kang‐Lin Hsieh, Germán Plascencia‐Villa, Ko‐Hong Lin, et al.
iScience (2022) Vol. 26, Iss. 1, pp. 105678-105678
Open Access | Times Cited: 11
Alzheimer’s Disease in Lebanon: Exploring Genetic and Environmental Risk Factors—A Comprehensive Review
Mohamad A. Khaled, Hadi Al-Jamal, Layla Tajer, et al.
Journal of Alzheimer s Disease (2024) Vol. 99, Iss. 1, pp. 21-40
Closed Access | Times Cited: 2
The effects of trazodone on human cognition: a systematic review
Ana Mafalda Gonçalves Gonçalo, Maria Augusta Vieira‐Coelho
European Journal of Clinical Pharmacology (2021) Vol. 77, Iss. 11, pp. 1623-1637
Open Access | Times Cited: 15
Neuroplasticity: The Critical Issue for Alzheimer's Disease and Links to Obesity and Depression
J. Wesson Ashford
American Journal of Geriatric Psychiatry (2023) Vol. 31, Iss. 10, pp. 867-875
Closed Access | Times Cited: 6
Established amyloid‐β pathology is unaffected by chronic treatment with the selective serotonin reuptake inhibitor paroxetine
Maurizio Severino, Mithula Sivasaravanaparan, Louise Ørum Olesen, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2018) Vol. 4, Iss. 1, pp. 215-223
Open Access | Times Cited: 18
On the Possible Relevance of Bottom-up Pathways in the Pathogenesis of Alzheimer’s Disease
Friedrich Leblhuber, Kostja Steiner, Simon Geisler, et al.
Current Topics in Medicinal Chemistry (2020) Vol. 20, Iss. 15, pp. 1415-1421
Closed Access | Times Cited: 13
Trazodone increases seizures in a genetic WAG/Rij rat model of absence epilepsy while decreasing them in penicillin-evoked focal seizure model
Hatice Aygün
Epilepsy & Behavior (2019) Vol. 103, pp. 106847-106847
Closed Access | Times Cited: 11
Prednisolone induces sleep disorders via inhibition of melatonin secretion by the circadian rhythm in zebrafish
Yu Jiang, Nan Gen, Peisong Wang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 147, pp. 112590-112590
Open Access | Times Cited: 7
Real-World Characteristics and Treatment Patterns of Patients With Insomnia Prescribed Trazodone in the United States
Ilena Pochiero, Manuela Gorini, Alessandro Comandini, et al.
Clinical Therapeutics (2022) Vol. 44, Iss. 8, pp. 1093-1105
Closed Access | Times Cited: 6
Treatment-induced mood switching in affective disorders
Siu Wa Tang, Wayne H. Tang, Brian E. Leonard
Acta Neuropsychiatrica (2021) Vol. 34, Iss. 2, pp. 55-68
Open Access | Times Cited: 7
No Association Between Trazodone and Corrected-QT Prolongation in Older Adults
Sabrina E.M. Armstrong, Hilary K. Brown, Carrie Shorey, et al.
Journal of Clinical Psychopharmacology (2019) Vol. 39, Iss. 5, pp. 528-530
Closed Access | Times Cited: 6
Dissociation of Arousal Index Between REM and NREM Sleep in Elderly Adults with Cognitive Impairment, No Dementia: A Pilot Study
Alejandra Rosales-Lagarde, Lourdes Cubero‐Rego, Federico Menéndez-Conde, et al.
Journal of Alzheimer s Disease (2023) Vol. 95, Iss. 2, pp. 477-491
Closed Access | Times Cited: 2
Case report: Personalizing the use of trazodone in real-world patients: a study of three cases of depression with comorbidities
Gianluca Rosso, Beatrice Benatti, Mauro Pettorruso, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access
Melatonin Ameliorates Abnormal Sleep-Wake Behavior via Facilitating Lipid Metabolism in a Zebrafish Model of Parkinson’s Disease
Meng‐Zhu Pang, Han-Xing Li, Xue-Qin Dai, et al.
Neuroscience Bulletin (2024) Vol. 40, Iss. 12, pp. 1901-1914
Closed Access
A Randomized-Controlled Trial Targeting Cognition in Early Alzheimer’s Disease by Improving Sleep with Trazodone (REST)
Estelle Eyob, Jacob S. Shaw, Arnold Bakker, et al.
Journal of Alzheimer s Disease (2024) Vol. 101, Iss. s1, pp. S205-S215
Closed Access
Low serum serotonin is associated with functional decline, mild behavioural impairment and brain atrophy in dementia-free subjects
Ming Ann Sim, Yingqi Liao, Siew Pang Chan, et al.
Brain Communications (2024) Vol. 7, Iss. 1
Open Access
The Relationship Between Sleep Quality, Sleep-Related Biomarkers, and Motor Skill Acquisition in People With Multiple Sclerosis: A Pilot Study
Alham Al‐Sharman, Heba Mefleh Al-khazaaleh, Hanan Khalil, et al.
Physical Therapy (2021) Vol. 101, Iss. 10
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top